COUNTERING US SANCTIONS pharmabiz.com In 2012, India issued its first ever compulsory license to domestic drug company, Natco Pharma Ltd, for a kidney and liver cancer drug, Nexavar, patented by Germany's Bayer AG. In 2013, India's Supreme Court rejected the patent claim of Novartis for ... |
